GB201810553D0 - 18F - Fluciclovine compositions in citrate buffers - Google Patents

18F - Fluciclovine compositions in citrate buffers

Info

Publication number
GB201810553D0
GB201810553D0 GBGB1810553.6A GB201810553A GB201810553D0 GB 201810553 D0 GB201810553 D0 GB 201810553D0 GB 201810553 A GB201810553 A GB 201810553A GB 201810553 D0 GB201810553 D0 GB 201810553D0
Authority
GB
United Kingdom
Prior art keywords
fluciclovine
compositions
citrate buffers
citrate
buffers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1810553.6A
Other versions
GB2561122A (en
GB2561122B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GB1810553.6A priority Critical patent/GB2561122B/en
Priority claimed from GB1408239.0A external-priority patent/GB2509476B/en
Publication of GB201810553D0 publication Critical patent/GB201810553D0/en
Publication of GB2561122A publication Critical patent/GB2561122A/en
Application granted granted Critical
Publication of GB2561122B publication Critical patent/GB2561122B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0404Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001Acyclic or carbocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB1810553.6A 2012-12-21 2012-12-21 Composition comprising [18F]-Fluciclovine Active GB2561122B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1810553.6A GB2561122B (en) 2012-12-21 2012-12-21 Composition comprising [18F]-Fluciclovine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1810553.6A GB2561122B (en) 2012-12-21 2012-12-21 Composition comprising [18F]-Fluciclovine
GB1408239.0A GB2509476B (en) 2011-12-21 2012-12-21 18F - Fluciclovine compositions in citrate buffers

Publications (3)

Publication Number Publication Date
GB201810553D0 true GB201810553D0 (en) 2018-08-15
GB2561122A GB2561122A (en) 2018-10-03
GB2561122B GB2561122B (en) 2019-07-17

Family

ID=63143587

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1810553.6A Active GB2561122B (en) 2012-12-21 2012-12-21 Composition comprising [18F]-Fluciclovine

Country Status (1)

Country Link
GB (1) GB2561122B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4550141B2 (en) * 2006-05-11 2010-09-22 日本メジフィジックス株式会社 Method for producing radioactive fluorine-labeled organic compound
TWI406674B (en) * 2007-02-13 2013-09-01 Nihon Mediphysics Co Ltd Method for manufacturing diagnostic radiographic diagnostic agents

Also Published As

Publication number Publication date
GB2561122A (en) 2018-10-03
GB2561122B (en) 2019-07-17

Similar Documents

Publication Publication Date Title
HUS2200034I1 (en) Glycoconjugation processes and compositions
IL235875A0 (en) Xylitol-based anti-anti-mucosal composition and related methods and compositions
EP2836212A4 (en) Novel compositions and methods
ZA201306391B (en) Nanoparticle compositions
PT2793954T (en) 18f - fluciclovine compositions in citrate buffers
GB201209268D0 (en) Surfactant composition
GB201113770D0 (en) Novel compositions and uses thereof
GB201215380D0 (en) Methods and compositions
ZA201308892B (en) Compositions and methods
GB201315347D0 (en) Methods and compositions
EP2874641A4 (en) Glutathione-elevating compositions and uses thereof
EP2668044A4 (en) Compositions and their use
EP2819668A4 (en) Ritonavir compositions
IL232397A (en) 18f-fluciclovine compositions in citrate buffers
GB201106357D0 (en) Composition and uses thereof
EP2766357A4 (en) Meso-biliverdin compositions and methods
EP2834635A4 (en) Heparin-bulking agent compositions and methods thereof
EP2806871A4 (en) Compositions and methods for improving lactation
SI2830587T1 (en) Dermo-protective and dermo-balancing composition
GB201810553D0 (en) 18F - Fluciclovine compositions in citrate buffers
ZA201404932B (en) 18f-fluciclovine compositions in citrate buffers
GB201107454D0 (en) Compositions and uses
GB201101924D0 (en) Compositions and uses
GB201120470D0 (en) Compositions and uses thereof
GB201116340D0 (en) Compositions and methods